Surgical Safety of Deferred Cytoreductive Nephrectomy Following Pretreatment with Immune Checkpoint Inhibitor-based Dual Combination Therapy

被引：18
|
作者：
Graafland, Niels M. [1 ,2 ]
Szabados, Bernadett [3 ]
Tanabalan, Chandran [4 ]
Kuusk, Teele [5 ]
Mumtaz, Faiz [5 ]
Barod, Ravi [5 ]
Nicol, David [4 ]
Boleti, Ekaterini [5 ]
Powles, Tom [3 ,5 ]
Haanen, John B. [6 ]
Bex, Axel [1 ,2 ,5 ,7 ]
机构：
[1] Netherlands Canc Inst, Dept Urol, Amsterdam, Netherlands
[2] Renal Canc Network, Amsterdam, Netherlands
[3] Barts Canc Ctr, Dept Med Oncol, London, England
[4] Royal Marsden Hosp, Dept Urol, London, England
[5] Royal Free London NHS Fdn Trust, Specialist Ctr Kidney Canc, London, England
[6] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
[7] UCL, Div Surg & Intervent Sci, London, England
来源：
EUROPEAN UROLOGY ONCOLOGY | 2022年 / 5卷 / 03期
关键词：
D O I：
10.1016/j.euo.2021.11.004
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：373 / 374
页数：2
相关论文
共 50 条
  • [1] The role of deferred cytoreductive nephrectomy in the era of immune checkpoint inhibitor
    Yaegashi, Hiroshi
    ANNALS OF ONCOLOGY, 2023, 34 : S1362 - S1362
  • [2] Indications and Outcomes for Deferred Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Combination Therapy: Can Systemic Therapy be Withdrawn in Patients with No Evidence of Disease?
    van de Putte, Elisabeth E. Fransen
    van den Brink, Luna
    Mansour, Mohamed A.
    van der Mijn, Johannes C.
    Wilgenhof, Sofie
    van Thienen, Johannes V.
    Haanen, John B. A. G.
    Boleti, Ekaterini
    Powles, Thomas
    Zondervan, Patricia J.
    Graafland, Niels M.
    Bex, Axel
    EUROPEAN UROLOGY OPEN SCIENCE, 2023, 55 : 15 - 22
  • [3] Theoretic strategy for immune checkpoint inhibitor-based combination therapy
    Chamoto, Kenji
    Hung, Mien-Chie
    CANCER SCIENCE, 2022, 113 : 1247 - 1247
  • [4] Surgical safety of Cytoreductive Nephrectomy (CN) following pretreatment with Immune Checkpoint Inhibition (ICI) combination therapy in primary metastatic clear-cell Renal Carcinoma (mccRCC)
    Graafland, N. M.
    Szabados, B.
    Mumtaz, F.
    Barod, R.
    Nicol, D.
    Tanabalan, C.
    Boleti, E.
    Powles, T.
    Haanen, J.
    Bex, A.
    EUROPEAN UROLOGY, 2021, 79 : S896 - S896
  • [5] Immune Checkpoint Inhibitor-Based Combination Therapy for Colorectal Cancer: An Overview
    Li, Jingjing
    Xu, Xuanfu
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 1527 - 1540
  • [6] Marker-guided immune checkpoint inhibitor-based combination therapy
    Hung, Mien-Chie
    CANCER SCIENCE, 2022, 113 : 1248 - 1248
  • [7] Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals
    Shapiro, Daniel D.
    Karam, Jose A.
    Zemp, Logan
    Master, Viraj A.
    Sexton, Wade J.
    Ghasemzadeh, Ali
    Schmeusser, Benjamin N.
    Davaro, Facundo
    Peak, Taylor
    Patil, Dattatraya
    Matin, Surena
    Spiess, Philippe E.
    Abel, Jason
    EUROPEAN UROLOGY OPEN SCIENCE, 2023, 50 : 43 - 46
  • [8] Side-effects of checkpoint inhibitor-based combination therapy
    Kourie, Hampig R.
    Klastersky, Jean A.
    CURRENT OPINION IN ONCOLOGY, 2016, 28 (04) : 306 - 313
  • [9] Immune Checkpoint Inhibitor-Based Strategies for Synergistic Cancer Therapy
    He, Mengying
    Yang, Tao
    Wang, Yuhan
    Wang, Mengyuan
    Chen, Xingye
    Ding, Dawei
    Zheng, Yiran
    Chen, Huabing
    ADVANCED HEALTHCARE MATERIALS, 2021, 10 (09)
  • [10] Immune checkpoint inhibitor-based therapy for advanced acral and mucosal melanoma
    Mori, Tatsuhiko
    Izumi, Teruaki
    Doi, Reiichi
    Kamimura, Anna
    Takai, Sayaka
    Teramoto, Yukiko
    Nakamura, Yasuhiro
    EXPERIMENTAL DERMATOLOGY, 2023, 32 (03) : 276 - 289
12345